World Pet Obesity Association
Clinical obesity case review · a teaching companion to the WPOA Clinical Guide v0.50
Three A’s case review
Classify adiposity. Diagnose clinical obesity only when all Three A’s are met.
A structured walk-through for skeletally mature dogs and cats, from body condition score to a documented four-tier classification, a chart note, and an owner conversation.
Confirm obesity-range body fat. BCS 7/9 opens the Clinical Obesity Screening Zone but stays overweight.
Complete the clinical MOD and decide whether the core laboratory database is indicated.
Document a clinically meaningful problem beyond the body condition score itself.
Weigh whether excess adiposity plausibly causes, worsens, or sustains that problem in this patient.
The Three A’s are diagnostic checks, not severity stages and not treatment barriers. Obesity-focused care begins when the screening zone is entered, not once a disease stage is assigned.
| Classification | Typical finding | What it means |
|---|---|---|
| Healthy body condition | BCS 4–5/9 | Reference state, not an obesity tier. Continue prevention. |
| Overweight | BCS 6–7/9 | Adiposity above the healthy range. BCS 7/9 begins the Clinical Obesity Screening Zone and stays overweight. |
| Obesity (descriptive) | Usually BCS 8–9/9 | Obesity-range adiposity confirmed; disease stage not yet assigned or attribution unresolved. |
| Pre-clinical obesity | Usually BCS 8–9/9 | No adiposity-related abnormality found after appropriate assessment. A call-to-action tier, not reassurance. |
| Clinical obesity | All Three A’s documented | Disease-stage diagnosis. Obesity-first, not obesity-only, care. |
This is a WPOA teaching implementation of a proposed framework. It is not an externally validated diagnostic instrument, a standard of care, or a substitute for patient-specific veterinary judgment. Classification must never delay urgent or disease-specific care.
Evidence base, thresholds, and limits
The clinical versus pre-clinical distinction is adapted from the 2025 Lancet Diabetes & Endocrinology Commission on Clinical Obesity and the 2025 Veterinary Record companion-animal proposal. The four-tier routing, the Three A’s, the Minimum Obesity Database, and the Obesity Pentad are WPOA implementation constructs, not separately validated diagnostic criteria.
Thresholds are operational. BCS 8–9/9 is a practical classification rule, not a point at which biology changes. BCS is semiquantitative and observer-dependent, varies with species, breed, conformation, coat, and palpation technique, and loses resolution at the upper end of the scale. Risk is continuous; drawing the line does not withhold care from the patient below it.
Laboratory values do not diagnose clinical obesity. Normal results do not exclude functional disease. Abnormal results do not establish Attribution. Research-derived thresholds remain risk flags unless validated for the species and clinical use.
Sources: Rubino et al. 2025; German et al. 2025; Cline et al. 2021 (AAHA); Freeman et al. 2011 (WSAVA); BSAVA obesity position statement.
Step 1 · Adiposity
Confirm the body-fat category
Score body condition on a species-appropriate 9-point chart by sight and palpation. Record muscle condition separately: it identifies muscle loss and discordance, but it cannot confirm or reclassify fat.
The patient stays classified as overweight. The score is a call to expand the assessment, not a disease-stage diagnosis. Revise the adiposity classification only after repeat scoring by a trained examiner or an independent adiposity method supports the obesity range.
Counsel and monitor. Obesity-range adiposity is not present, so clinical obesity cannot be assigned. Obesity-focused assessment is still appropriate earlier than the screening zone when there is clinical concern.
The adiposity interpretation appears here.
Patient context and adult weight trend (optional)
Patient context
Context informs the plan and the laboratory decision. It does not set the adiposity category.
This tool is for skeletally mature patients. Ages under 1 year need confirmation that growth is complete.
Adult weight trend
Percentage change adds trajectory context and supports the “rapid gain” judgment that triggers expanded assessment. It does not measure body fat.
Earlier measurement
Later measurement
Select Adult or Senior to use the calculator.
These bands describe how much was gained, not how fast. Read them with the elapsed time. Rapid gain remains a clinical judgment rather than a fixed numeric rate.
Step 2 · Minimum Obesity Database
Build the baseline assessment
The clinical MOD is completed whenever BCS 7/9 or higher triggers obesity-focused assessment. The core laboratory database is a separate decision. Screen everyone; test selectively but consistently.
The interpretation appears here.
Mark each analyte to see the suggested next steps.
Pentad interpretation, confounders, and next steps
| Analyte | Why reviewed | Common confounders | Practical next step |
|---|
Species notes
Dogs. Obesity can produce insulin resistance and compensatory hyperinsulinemia, but current evidence does not support a routine canine pathway to type 2 diabetes analogous to cats and people. Fasting glucose is an insensitive obesity marker in dogs, and insulin-based indices are specialist or research tools.
Cats. Persistent hyperglycemia requires confirmation of sustained dysglycemia using repeat or home glucose assessment, continuous glucose monitoring where available, fructosamine, glucosuria, clinical signs, and patient context. A single stressed in-hospital glucose value is not sufficient.
Research patterns, not cutoffs
Research-derived canine lipid flags and the proposed feline triglyceride–ALT–SAA pattern are risk flags or proposed frameworks, not validated diagnostic cutoffs. The feline pattern derives from a single small cohort and uses a BCS ≥7/9 entry point that sits below this framework’s obesity-range threshold, a further reason to treat it as a research flag.
Tiered laboratory assessment: what each tier is for
Laboratory tiers describe the intensity of testing, not the patient’s disease stage.
| Tier | Use when | Examples |
|---|---|---|
| Tier 1 · MOD | Default when BCS 8–9/9 is first disease-staged, or any BCS ≥7/9 enters structured weight management, or a clinical, risk, recency, or safety trigger is present. | Clinical MOD plus CBC, comprehensive chemistry, urinalysis, and the Obesity Pentad review. |
| Tier 2 · targeted | Abnormal MOD, clinical signs, comorbidity, discordant pattern, poor response, appetite concern in cats, or a safety concern. | Fructosamine, home or continuous glucose assessment, blood pressure, urine protein-to-creatinine ratio, endocrine testing, canine CRP or feline SAA when justified. |
| Tier 3 · referral | Severe, progressive, multisystem, refractory, or unclear findings. | Advanced endocrine, lipid, inflammatory, imaging, genetic, metabolic, or body-composition testing. |
CRP and SAA are nonspecific inflammatory markers. Interpret them only in the clinical and assay context in which they were obtained. Adipokines such as leptin and adiponectin are biologically informative but are not routine MOD markers.
Complete the clinical components and record the laboratory decision.
Step 3A · Abnormality
Identify possible abnormalities
Abnormality means a documented, clinically meaningful problem beyond excess adiposity itself. Isolated, transient, or clinically trivial findings do not qualify.
Five-step method for documenting Abnormality
Use these steps instead of vague impressions such as “slowing down” or “less active.”
| Step | Action | Example wording |
|---|---|---|
| 1 | Ask about one normal activity the patient used to perform. | Can she still jump up to her favorite place? |
| 2 | Observe, measure, or review supporting evidence. | Owner video shows two failed attempts to jump onto the couch. |
| 3 | Record the change, duration, and daily impact. | Difficulty rising after rest for 3 months; walks shortened from 30 to 10 minutes. |
| 4 | Consider other likely explanations. | Osteoarthritis pain, neurologic disease, airway disease, medications, or environmental change considered. |
| 5 | State what will be checked again. | Recheck mobility score after pain control, activity plan, and adiposity reduction. |
The tool will route the next step.
Step 3B · Abnormality
Confirm what counts as an Abnormality
One finding at a time. A finding counts only when it is ongoing or consequential, clinically supported, and clinically meaningful.
One day of uncomplicated vomiting that resolves completely may need treatment, but it does not meet the Abnormality criterion. A sudden event can still count when it causes or reveals ongoing dysfunction. Step 4 decides whether excess adiposity is involved.
“No abnormality identified” means none was found after appropriate history, examination, function review, and clinically indicated diagnostics. It does not mean every possible test was performed. A patient classified pre-clinical after a limited assessment may be reclassified later; the label describes today’s evidence, not a fixed endpoint.
Step 4 · Attribution
Weigh Attribution, one finding at a time
Attribution is an inference, not a finding. Sole causation and exhaustive exclusion are not required, but the record should state the patient-specific basis for the link.
Mechanism, alternatives, and evidence that may help
Supports Attribution
Mark what is true for this patient.
Argues against
Points toward comorbidity or a pending call.
The same diagnosis can be a complication in one patient and a comorbidity in another. Osteoarthritis in a dog at BCS 9/9 whose pain and mobility clearly worsen under the fat burden is an adiposity-related complication. The same osteoarthritis, when primary joint disease fully explains the signs, is a comorbidity. Improvement as adiposity falls strengthens Attribution, especially when timing, magnitude, and mechanism align, but concurrent interventions mean response rarely proves sole causation.
Best-supported classification
Overweight
How the Three A’s resolved
Finding by finding
Patient and assessment context
What this means
Next clinical actions
Suggested medical-record wording
Match the words to the evidence and update the entry as the patient is reassessed.
Explaining it to the owner
Compare with the guide
Review or change an answer
Answers are kept when you move between steps.
Classification is iterative. Update the stage as evidence, function, and response change. This tool implements the WPOA Clinical Guide v0.50 and the proposed four-tier framework; the routing and wording are WPOA implementation constructs rather than externally validated diagnostic criteria. It does not replace patient-specific veterinary judgment, and it must never delay urgent or disease-specific care.